Neurotech International (NTI) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Rare opportunities – ASX health stocks tackling unmet medical needsFebruary 13, 2025 | msn.comIs There Now An Opportunity In Neurotech International Limited (ASX:NTI)?December 6, 2024 | finance.yahoo.comNeurotech Director Increases Shareholding in CompanyDecember 6, 2024 | markets.businessinsider.comNeurotech International’s AGM Success and Trial ProgressNovember 20, 2024 | markets.businessinsider.comNeurotech’s NTI164 Shows Promise in Neurological TreatmentNovember 12, 2024 | markets.businessinsider.comDr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025November 11, 2024 | msn.comNeurotech International Appoints New CEO to Drive GrowthNovember 10, 2024 | markets.businessinsider.comNeurotech International to Issue 20 Million OptionsNovember 10, 2024 | markets.businessinsider.comEstimating The Intrinsic Value Of Neurotech International Limited (ASX:NTI)October 26, 2024 | uk.finance.yahoo.comNeurotech International Advances in Neurological Disorder TreatmentsOctober 23, 2024 | markets.businessinsider.comNeurotech knocked back by FDA as agency declares target condition not rare enough for special statusOctober 4, 2024 | msn.comWe're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn RateSeptember 30, 2024 | finance.yahoo.comAustralia proves its reputation as ‘go-to’ destination for clinical trialsSeptember 18, 2024 | msn.comNeurotech International Ltd Investor Webinar TranscriptSeptember 14, 2024 | gurufocus.comNeurotech International Ltd Rett Syndrome Phase I Or II Trial Results Webinar TranscriptSeptember 14, 2024 | gurufocus.comBreak it Down: Neurotech gives something to think aboutSeptember 9, 2024 | msn.comNeurotech’s cannabinoid drug reverses immune dysregulation in PANDAS/PANS kidsSeptember 9, 2024 | msn.comThe 18% return this week takes Neurotech International's (ASX:NTI) shareholders five-year gains to 500%August 19, 2024 | finance.yahoo.comNeurotech’s Rett Syndrome trial shows improvement in extension stageJuly 31, 2024 | msn.comNeurotech Phase 2/3 autism trial shows uplift in mood while lowering anxiety and depressionJuly 19, 2024 | msn.comDespite Setback, Neuralink’s First Brain-Implant Patient Stays UpbeatMay 22, 2024 | nytimes.comNTI 2024: Flosonics Medical Presents Educational Dinner Symposium on the Future of Sepsis ResuscitationMay 17, 2024 | markets.businessinsider.comNeuralink's first patient said he 'cried a little bit' after his brain implant started malfunctioningMay 16, 2024 | msn.comNeurotech reports more positive Phase 1/2 Rett Syndrome clinical trial resultsMay 6, 2024 | msn.comPharmAust plans for pivotal Phase 2/3 trial after key quarter of milestonesApril 30, 2024 | msn.comNeurotech’s Phase 2/3 autism trial meets primary endpointApril 17, 2024 | msn.comNeurotech hits new milestone in Phase II/III autism trial after treating last patientApril 10, 2024 | msn.comNeuroVigil, World's Most Valuable Neurotech, Launches iBrain™ in USApril 5, 2024 | tmcnet.comNeuroVigil, World's Most Valuable Neurotech Company, Launches in USApril 5, 2024 | tmcnet.comNeurotech extends clinical trials for the $US2bn Rett Syndrome marketMarch 13, 2024 | msn.comNeurotech International's (ASX:NTI) investors will be pleased with their massive 340% return over the last five yearsFebruary 27, 2024 | finance.yahoo.comMarket Highlights: Chipmaker Arm up 29pc, Bitcoin tops US$50k, and 5 ASX small caps to watch todayFebruary 13, 2024 | msn.comMicroPort NeuroTech Ltd 02172February 7, 2024 | morningstar.comNeurotech gets green light to start phase I/II cerebral palsy trialJanuary 28, 2024 | msn.comNeurotech moves to show economic advantage of autism treatment as Phase II/III trial results due soonJanuary 24, 2024 | msn.comWhat’s in store for 2024: Neurotech InternationalJanuary 16, 2024 | msn.comPart 1: ASX biotechs with catalysts looking to pop in 2024December 26, 2023 | msn.comNeurotech completes recruitment in Phase 2/3 autism spectrum disorder trialDecember 18, 2023 | msn.comNeurotech to extend Phase 2/3 autism spectrum disorder trial to adultsDecember 3, 2023 | msn.comNeurotech treatment looks to be making a difference in children with PANDAS/PANS in Phase I/II clinical trialOctober 8, 2023 | msn.comMotif Neurotech Conducts First-in-human Brain Stimulation With Millimeter-sized Implantable Device for Treatment-resistant DepressionSeptember 22, 2023 | businesswire.comNorthern Trust Asset Management Names New CIO of Global Asset AllocationSeptember 7, 2023 | benzinga.comMoneyTalks: Merchant Group’s Andrew Chapman has his eye on these diagnostic biotech stocksAugust 14, 2023 | msn.comHere's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn SituationJune 27, 2023 | finance.yahoo.comNeurotech International Ltd (NTI)June 21, 2023 | uk.investing.comASX Health Stocks: Neurotech says NTI164 works well in 11 autistic children after 52 weeks of treatmentMarch 17, 2023 | msn.comArovella Therapeutics recruits biotech stalwart as non-executive chairMarch 12, 2023 | proactiveinvestors.com.auNeurotech International Limited (NTI.AX)January 15, 2023 | au.finance.yahoo.comNeurotech Devices Market is projected to grow at a CAGR of 13.78% by 2033: Visiongain Reports LtdJanuary 14, 2023 | benzinga.comWe Think Neurotech International (ASX:NTI) Needs To Drive Business Growth CarefullyJanuary 14, 2023 | finance.yahoo.com Get Neurotech International News Delivered to You Automatically Sign up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter. Email Address NTI Media Mentions By Week NTI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTI News Sentiment▼0.800.60▲Average Medical News Sentiment NTI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTI Articles This Week▼00▲NTI Articles Average Week Get Neurotech International News Delivered to You Automatically Sign up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zion Oil & Gas News Evolution Petroleum News Gran Tierra Energy News Global X Active Canadian Dividend ETF Common News Epsilon Energy News Mammoth Energy Services News InPlay Oil News Intermap Technologies News KLX Energy Services News U.S. Energy News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NTI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotech International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotech International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
